Peera Buranakitjaroen Selected Research

Peera Buranakitjaroen Research Topics

18	Hypertension (High Blood Pressure) 01/2022 - 11/2006
3	Masked Hypertension 01/2020 - 01/2020
2	Stroke (Strokes) 01/2022 - 01/2019
2	Chronic Renal Insufficiency 01/2021 - 02/2012
2	Erectile Dysfunction 01/2021 - 06/2007
2	Diabetes Mellitus 01/2019 - 11/2006
2	Dyslipidemias (Dyslipidemia) 06/2007 - 01/2007
2	Essential Hypertension 10/2003 - 09/2002
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Heart Failure 01/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Cough 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Dementia (Dementias) 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Hypoaldosteronism (Hyporeninemic Hypoaldosteronism) 10/2015
1	Hemorrhagic Stroke 03/2014
1	Overweight 11/2006

5	SaltsIBA 01/2021 - 02/2013
5	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 01/2020 - 01/2018
4	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 11/2006
3	Pharmaceutical PreparationsIBA 01/2021 - 03/2014
2	CholesterolIBA 01/2022 - 01/2021
2	Angiotensin Receptor AntagonistsIBA 01/2020 - 09/2002
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 06/2009
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2020
1	Drug CombinationsIBA 01/2020
1	Nebivolol FDA Link 01/2016
1	PotassiumIBA 10/2015
1	SodiumIBA 02/2013
1	Glucose (Dextrose)FDA LinkGeneric 02/2012
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 06/2009
1	Losartan (Cozaar)FDA LinkGeneric 06/2009
1	Sildenafil Citrate (Viagra)FDA Link 06/2007
1	oxidized low density lipoproteinIBA 01/2007
1	Atorvastatin (Lipitor)FDA Link 01/2007
1	DiureticsIBA 11/2006
1	Rilmenidine (Hyperium)IBA 10/2003
1	Telmisartan (Micardis)FDA Link 09/2002